Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress
Monoamine oxidase B (MAO-B) is responsible for dopamine metabolism and plays a key role in oxidative stress by changing the redox state of neuronal and glial cells. To date, no disease-modifying therapy for Parkinson’s disease (PD) has been identified. However, MAO-B inhibitors have emerged as a via...
Main Authors: | Mohamed H. Elsherbeny, Jushin Kim, Noha A. Gouda, Lizaveta Gotina, Jungsook Cho, Ae Nim Pae, Kyeong Lee, Ki Duk Park, Ahmed Elkamhawy, Eun Joo Roh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/10/1641 |
Similar Items
-
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
by: Ahmed Elkamhawy, et al.
Published: (2021-10-01) -
Ageing and Neurodegeneration – The Role of Neurotransmitters’ Activity
by: Bonka Lozanska, et al.
Published: (2022-12-01) -
Evaluation of 6-Hydroxydopamine and Rotenone In Vitro Neurotoxicity on Differentiated SH-SY5Y Cells Using Applied Computational Statistics
by: Rui F. Simões, et al.
Published: (2022-03-01) -
Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches
by: Linfeng Zheng, et al.
Published: (2022-10-01) -
Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
by: Narayan D. Chaurasiya, et al.
Published: (2022-07-01)